COVID-19 vaccine scheme for world’s poorest pushes for delivery slowdown

Leaders of the global scheme aiming to get COVID-19 vaccines to the world’s poorest are pushing manufacturers including Pfizer (PFE.N) and Moderna (MRNA.O) to cut or slow deliveries of about half a billion shots so doses are not wasted.
EXCLUSIVE EU, Gates Foundation to support African medicines agency -source
BRUSSELS, Feb 11 (Reuters) – The European Union and the Gates Foundation are set to announce a package of financial support for the nascent efforts to set up an African medicines regulator in a bid to boost the continent’s drugs and vaccine production, a person familiar with the matter told Reuters. The treaty establishing the […]
GSK sees sales growth in 2022 after quarterly beat, prepares for spin-off

Britain’s GSK (GSK.L) forecast growth in 2022 after racking up 1.4 billion pounds ($1.9 billion) in COVID-related sales in 2021, beating quarterly forecasts in its first earnings report since rejecting Unilever’s (ULVR.L) bid for its consumer arm.
Exclusive: Pfizer to cut U.S. sales staff as meetings with healthcare providers move to virtual

Pfizer Inc (PFE.N) said on Tuesday it is reducing its U.S. sales staff as it expects doctors and other healthcare providers to want fewer face-to-face interactions with sales people after the COVID-19 pandemic ends.
U.S. reports 1.35 million COVID-19 cases in a day, shattering global record

The United States reported 1.35 million new coronavirus infections on Monday, according to a Reuters tally, the highest daily total for any country in the world as the spread of the highly contagious Omicron variant showed no signs of slowing.
S&P 500, Dow hit record highs on 1st trading day of 2022

The S&P 500 (.SPX) and Dow Jones Industrial Average (.DJI) posted closing record highs on the first trading day of the year on Monday, helped by gains in Tesla Inc (TSLA.O)and bank shares.
U.S. Supreme Court to take up Biden vaccine mandate cases

The U.S. Supreme Court agreed on Wednesday to take up disputes over the Biden administration’s nationwide vaccine-or-testing COVID-19 mandate for large businesses and a separate vaccine requirement for healthcare workers.
Analysis: Jabs for jobs: U.S. vaccine mandates offer bargaining chip for worker rights

U.S. vaccine mandates are giving workers greater negotiating power, experts say, as the threat of strikes and collective action wins concessions for workers pummeled by the pandemic.
U.S. SEC to tighten insider trading rules, boost money market fund resilience

The U.S. Securities and Exchange Commission (SEC) on Wednesday proposed tightening a legal safe-harbor that allows corporate insiders to trade in a company’s shares, and other rules to improve the resilience of money market funds.
Special Report: U.S. rushed contracts to COVID-19 suppliers with troubled plants

As the Trump administration debated whether to declare COVID-19 a national emergency early last year, a little-known U.S. health office issued a public plea to Big Pharma.